Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Journal of Pharmacy Practice
Over the last decade, Glucagon-like peptide-1 (GLP-1) based therapies have revolutionised diabetes treatment and are now set to massively impact the management of obesity
Content Updated Date: Apr 2026 Author Muni Kumar Meravath Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc
All compounds are strictly for in-vitro research applications
US$ 27.37
US$ 21.38
US$ 27.87
,aspect=ignore)
US$ 28.76
US$ 22.79
US$ 25.91
:format(webp))
